Skip to main content
NCBI home page
Skull Base Reports logoLink to Skull Base Reports
. 2011 Aug 4;1(2):71–82. doi: 10.1055/s-0031-1284217

Chondroblastoma of the Temporal Bone: A Case Series, Review, and Suggested Management Strategy

Luke B Reid 1,✉, David S Wong 2, Bernard Lyons 2
PMCID: PMC3743598  PMID: 23984206

Abstract

Chondroblastoma of the temporal bone is a rare condition. Chondroblastomas account for less than 1% of primary bone tumors, and those involving the temporal bone represent a tiny fraction of these tumors with most arising from the knee, rib, and pelvis. We present a case series of two patients who presented with chondroblastomas of the temporal bone over a period of 8 years to the St. Vincent's Hospital in Melbourne, Victoria, Australia. In particular, we outline the presenting complaint, diagnostic imaging undertaken, and the importance of preoperative histopathology in coming to the diagnosis and subsequent resection undertaken. A review of the current literature is presented with a suggested management strategy for these tumors.

Keywords: Chondroblastoma, temporal bone, multidisciplinary, team, management

Chondroblastoma of the temporal bone is a rare condition.1 Chondroblastomas account for less than 1% of primary bone tumors,2 and those involving the temporal bone represent a tiny fraction of these tumors with most arising from the knee, rib, and pelvis.2

We present a case series of two patients who presented with chondroblastomas of the temporal bone over a period of 8 years to the St. Vincent's Hospital in Melbourne. We will also review the current literature and a suggested management strategy for these tumors.

Case Reports

Case 1

A 27-year-old woman with no previous medical history presented with several weeks' history of tinnitus and decreased hearing in the right ear. Physical examination revealed an external auditory canal mass as well as a slight swelling over the right squamous temporal bone region. There were no cranial nerve abnormalities. No formal audiovestibular testing was performed preoperatively.

The computed tomography (CT) and magnetic resonance imaging (MRI) scans demonstrated an aggressive looking destructive mass involving the right petrous temporal bone and temporomandibular joint, centered at the junction between the squamous and petrous temporal bones (Fig. 1A–C). A positron emission tomography (PET) scan revealed the lesion to be intensely metabolically active, in keeping with a malignancy. There was no evidence of metastatic disease on the CT brain/chest/abdomen/pelvis. Based on the biopsy result of a giant cell-rich lesion with pericellular calcification in keeping with a chondroblastoma, the patient underwent a partial temporal bone resection, parotidectomy, and mastoid meatoplasty with neurosurgical resection of the middle cranial fossa component. The tumor appeared to be entirely extradural. Of note, the facial nerve was dehiscent in the anterior epitympanum but not involved with tumor. The tumor was dissected free from this area. The patient made a good postoperative recovery.

Figure 1.

Figure 1

Open in a new tab

(A) Case 1: Axial CT bone windows. (B) Case 1: Axial T2 MRI. (C) Case 1: T2 Coronal MRI.

A complete right facial nerve palsy (House-Brackmann equivalent 6 [HBe6]) evolved while an inpatient (immediately postoperatively the patient had an HBe2). This complete palsy was present on discharge, but subsequently completely resolved 3 months postoperatively. Definitive histopathology on the resected specimen confirmed a chondroblastoma. Review at 18 months showed no evidence of tumor recurrence and normal facial nerve function.

Case 2

A 59-year-old woman with a history of type two diabetes mellitus complained of a right pre-auricular swelling that had slowly grown in size over the previous few months. This was associated with localized swelling in the right external auditory meatus, a right-sided facial weakness (HBe2), and mild hearing loss. No formal audiovestibular testing was performed preoperatively; however, free field whisper testing and tuning forks showed only a very small amount of conductive deafness.

The CT and MRI scans showed a lobulated mass in the subcutaneous tissues immediately lateral to the temporomandibular joint, involving the joint and partially encasing the head of the mandible. There was further infiltration into the right external ear canal with a larger soft tissue component in the dorsal aspect of the right zygomatic region (Fig. 2A, B).

Figure 2.

Figure 2

Open in a new tab

(A) Case 2: MRI Axial. (B) Case 2: MRI Coronal.

The bone scan highlighted scintigraphic uptake within the anteroinferior aspect of the base of the right petrous temporal bone (Fig. 3). A biopsy was consistent with a giant cell tumor of the right temporal bone.

Figure 3.

Figure 3

Open in a new tab

Case 2: Bone scan.

The patient underwent a right infratemporal fossa resection of tumor with partial parotidectomy and temporalis muscle rotation flap and reconstruction of the right ear canal. The superior division of the facial nerve was found to be associated with the tumor. These branches were dissected free of the tumor and reflected anteriorly. The facial nerve trunk was intact and the inferior division was not involved.

Postoperatively the patient made a good recovery and there was no facial nerve palsy present on discharge. The tumor diagnosis was revised to chondroblastoma on definitive histopathology. Review at 7 years showed no evidence of tumor recurrence.

Discussion

Chondroblastoma was first described in 1931 by Codman who originally described an “epiphyseal chondromatous giant cell tumor of the proximal humerus,” with the diagnosis corrected to chondroblastoma of bone by Jaffe and Lichtenstein in 1942.3

The following terms were used in the keywords search tool to do an Ovid Medline literature search with the date parameter 1950 to present:

  • Chondroblastoma + skull base

  • Chondroblastoma + temporal bone

  • Chondroblastoma + diagnosis + temporal bone

  • Chondroblastoma + temporal bone + skull base

Only English language journal articles or those translated into English were reviewed. These search strings plus review of the reference lists in the returned articles yielded 41 original articles reporting on a total of 79 cases of chondroblastoma of the temporal bone. Including this current case series, there are total of 81 reported cases worldwide of chondroblastoma of the temporal bone in the English Literature. Table 1 details a summary of those cases presented in the literature. A review of these 81 cases was performed, and an analysis was performed when complete datasets were available.

Table 1. Summary of Cases of Chondroblastomas of the Temporal Bone Published in the Literature: 1950 to Present.

Article Date Published Age Sex Presenting Symptom Side Preop biopsy Preop CT/MR Operation Radiotherapy Chemotherapy Follow-up (months) Recurrence
Anim et al12 1986 45 M Facial swelling, otorrhea, hearing loss Left Yes CT Radical resection No No 12 No
Ben Salem et al13 2002 31 F Otalgia, hearing loss, TMJ pain Right CT, MR Zygomatic extended middle fossa approach with resection of the involved squamous temporal bone and zygomatic arch No No 12 No
Bertoni et al14 1987 53 M ? ?? ? ? No ? ?
56 M Right ?? Curettage ? No 108 No
61 F ? ?? Curettage ? No ? ?
? ? ? ?? Excision No No 24 No
35 M Left Yes ?? Resection No No 12 No
46 M Blocked ear Left ?? ? ? No ? ?
63 M Blocked ear ? Yes ?? Curettage No No 28 No
40 M Trismus ? ?? Curettage Yes No 48 No
39 F TMJ pain Left ?? Excision No No 17 No
3 F Otorrhea ? ?? Curettage No No 48 No
70 F Otalgia Left ?? Craniotomy and mastoidectomy ? No ? ?
39 M Right Yes ?? Excision No No 6 Yes
52 M Hearing loss ? ?? Curettage No No ? ?
33 M Hearing loss ? Yes ?? Curettage No No 48 No
66 M Hearing loss Right ?? Curettage No No 72 No
45 M Facial swelling, Otorrhea, hearing loss Left ?? Excision No No 12 No
36 F Tinnitus, hearing loss Left Yes ?? Curettage No No 48 No
Bian et al15 2005 38 M Facial swelling, hearing loss Left CT, MR Zygomatic extended middle fossa approach with resection of the involved squamous temporal bone and zygomatic arch No No 12 No
Blaauw et al16 1988 16 M Facial swelling Right Yes CT Intracapsular removal Yes No 6 Yes
Cabrera et al9 2006 31 F Facial swelling, otalgia Left Yes CT, MR Excision No No 12 No
Cares et al17 1971 30 F Facial swelling, blocked ear Left Curettage No No 24 No
Dahlin and Ivins18 1972 ? ? ? ?? Subtotal resection Yes No 7 No
? ? ? ?? Subtotal resection Yes No 7 No
Denko et al19 1955 53 M Facial swelling Right Curettage No No ? ?
Dran et al5 2007 12 F Hearing loss Left CT, MR Initially subtemporal and subdural approach with intracapsular removal. Second procedure—translabyrinthine combined with subtemporal way Yes No 1.5 Yes
Fares et al20 1997 ? ? ? ?? Subtotal resection ? ? ? ?
Feely and Keohane21 1984 42 F Otalgia Left CT Craniotomy with en bloc resection No No 36 No
Flowers et al4 1995 8 M Facial swelling Right Yes CT, MR En bloc resection No No ? ?
Gaudet et al22 2004 28 F Otalgia, hearing loss, blocked ear, TMJ pain Right Yes CT, MR En bloc resection No No 48 No
Harner et al11 1979 56 M Hearing loss, blocked ear Left Yes Mastoidectomy Yes No 35 No
57 M Tinnitus, hearing loss Left Mastoidectomy No No ? ?
39 M Hearing loss Right Yes Mastoidectomy Yes No 94 No
59 M Otalgia, otorrhea, hearing loss Left Yes CT En bloc resection Yes No ? No
Hirth et al23 1972 ? ? ? ?? ? ? ? ? ?
Hong et al24 1999 41 F TMJ pain Right CT, MR Curettage Yes Yes 27 No
58 F TMJ pain Right CT, MR Excision No No ? ?
57 F Left CT, MR Curettage Yes No 27 Yes
60 M Headache, tinnitus, hearing loss Left CT, MR Excision Yes No 37 No
52 F Tinnitus, hearing loss, blocked ear, TMJ pain Left CT, MR Excision No No 29 No
Horn et al25 1990 39 F Tinnitus, hearing loss Left Yes CT, MR Craniotomy and mastoidectomy No No 12 No
34 M Hearing loss Left Yes CT, MR Craniotomy and mastoidectomy No No 12 No
Ishikawa et al26 2002 24 M Facial swelling, trismus, TMJ pain Right CT, MR Craniotomy with attempted en bloc resection No No 24 Yes
Kobayashi et al27 2001 60 F Facial swelling, tinnitus, hearing loss Left CT, MR Curettage No No 18 No
Koerbel et al28 2007 27 F Headache, hearing loss Right ?? ? ? No ? ?
Kurokawa et al7 2005 49 M Right CT, MR Excision via a zygomatic approach No No 84 No
27 M Tinnitus, hearing loss, TMJ pain Right Yes ?? Excision via a zygomatic approach No No 156 No
29 M Hearing loss Right ?? Excision via a zygomatic approach No No 132 No
32 F Tinnitus, hearing loss Right Yes CT, MR Excision via a zygomatic approach No No 72 No
Kutz et al1 2007 39 F Headache, otalgia Left Yes CT, MR Preauricular infratemporal approach with all involved tumor removed resulting in gross resection No No 48 No
85 F Hearing loss Left CT, MR Initially underwent a mastoidectomy for presumed cholesterol granuloma. Subsequently underwent a transmastoid-subtemporal approach with R/O zygoma and supra-auricular temporal bone No No 36 No
39 F Hearing loss Right Yes CT, MR Infratemporal craniotomy and condylectomy with R/O condyle, labyrinth and cochlear. Tumor was dissected from the facial nerve, internal auditory canal fundus and dehiscent petrous carotid artery No No 36 No
70 M Tinnitus, hearing loss Right Yes CT Middle cranial fossa approach No No 216 No
62 F Otalgia, hearing loss, blocked ear Left CT, MR Craniotomy with en bloc resection No No 6 No
Leong et al29 1994 23 M Blocked ear Left Yes CT Cortical Mastoidectomy No No 11 No
31 M Otalgia, Tinnitus, otorrhea, hearing loss Left Yes CT, MR Subtotal petrosectomy/en bloc resection Yes No 8 No
Mizumatsu et al30 2008 52 F Otalgia Right CT, MR Previous surgical resection Yes No 48 No
Moon et al31 2008 22 F Facial swelling, blocked ear Left CT, MR Middle cranial fossa approach No No 34 No
48 F Facial swelling, trismus, hearing loss, TMJ pain Right CT, MR Mastoidectomy, parotidectomy and ITF approach type C No No 78 No
33 M Otalgia, otorrhea, hearing loss Right CT, MR Lateral temporal bone resection No No 70 No
33 M Hearing loss, blocked ear Right CT, MR Mastoidectomy No No 58 No
Moorthy et al32 2002 31 M Facial swelling Left CT, En bloc resection Yes No ? ?
Muntane et al33 1993 58 F Headache, hearing loss Right CT, MR En bloc resection No No ? ?
Narita et al34 1992 34 F Hearing loss Left CT, MR Subtotal resection No No ? ?
Rodríguez Paramás et al35 2006 31 M Otalgia Left Yes CT Craniofacial approach with complete removal No No ? ?
Piepgras et al36 1972 26 M Headache Right En bloc resection No No 12 No
Politi et al37 1991 53 M Facial swelling Left Yes CT Local excision and curettage No No 36 No
Pontius et al38 2003 38 M Facial swelling, otalgia, otorrhea, hearing loss Left Yes CT Craniotomy and mastoidectomy No No 12 No
Selesnick et al6 1999 30 F Otalgia, trismus, TMJ pain Right CT, MR Temporal craniectomy with resection of the condyle of the mandible No No 36 No
38 M Tinnitus, blocked ear Right CT, MR Subtemporal craniectomy and dissection of the middle fossa floor No No 36 No
Shimizu et al39 1997 30 M Hearing loss Left CT, MR Subtotal resection No No ? ?
Spjut et al40 1971 ? ? ? ? ?? ? ? ? ? ?
? ? ? ? ?? ? ? ? ? ?
Tanohata et al41 1986 55 F Headache, otalgia, tinnitus, hearing loss Left CT En bloc resection No No ? No
Vandenberg and Coley42 1950 39 M Hearing loss, Left Yes No Yes No 102 No
Varvares et al43 1992 33 M Headache, facial swelling, otalgia, hearing loss, TMJ pain Right CT, MR En bloc resection No No 24 No
Velizarov et al44 1971 ? ? ? ?? ? ? ? ? ?
Watanabe et al45 1999 43 F Hearing loss, blocked ear Left Mastoidectomy No No 48 No
Reid et al (current article) 2010 59 F Facial swelling Right Yes CT, MR Craniotomy mastoidectomy and parotidectomy No No 83 No
27 F Facial swelling, tinnitus, hearing loss Right Yes CT, MR Craniotomy and mastoidectomy No No 18 No
Open in a new tab

CT, computed tomography; F, female; ITF, infratemporal fossa; M, male; MR, magnetic resonance; TMJ temporomandibular joint.

Of the 73 patients with complete datasets there were 33 females and 40 males affected, giving a slight male predilection with a 1:1.2 female to male ratio.

Average age at presentation for females was 41 years (range, 3 to 85 years, standard deviation of 15.4 years; n = 33) with that for males 41 years (range, 8 to 70 years, standard deviation 15 years; n = 40). There was no right to left predilection (right = 30/left = 36/unknown = 15)

There was considerable variation in the presenting symptoms of chondroblastoma of the temporal bone. Table 2 lists the range of presenting symptoms of chondroblastoma of the temporal bone. The most common presenting symptoms are hearing loss (49% of reported cases), cranial nerve involvement (43.2%), facial swelling (22.2%), and otalgia (19.8%). A subgroup analysis was performed, but did not yield any useful guide regarding a constellation of symptoms typical of this pathology.

Table 2. Presenting Symptoms of Chondroblastoma of the Temporal Bone.

Symptom Percentage of Patients
Hearing loss 49.4
Cranial nerve involvement 43.2
Facial swelling 22.2
Otalgia 19.8
Tinnitus 16.0
Temporomandibular joint pain 13.6
Blocked ear/aural fullness 14.8
Pain 12.3
Headache 8.6
Otorrhea 8.6
Trismus 4.9
Open in a new tab

The surgical resection of these tumors again showed great heterogeneity in surgical approach. Earlier reports advocated “curettage” for the removal of these tumors, whereas subsequent contemporary articles took a more aggressive approach. Such approaches included “wide local excision,” “mastoidectomy with complete/en-bloc resection,” “craniotomy with en-bloc resection,” etc.

Fifteen patients received postoperative radiotherapy, who had had a variety of surgical approaches, with no consistent approach noted. Table 3 lists for those patients who received postoperative radiotherapy the surgical approach undertaken for resection of the chondroblastoma and the number of patients who were treated such. Only one patient received chemoradiotherapy who had undergone “curettage” as the primary procedure.

Table 3. Patients Treated with Postoperative Radiotherapy by Surgical Approach.

Surgical Approach Number of Patients
Curettage29,46 3
En bloc resection33 2
Excision46 1
Initially subtemporal and subdural approach with intracapsular removal 1
Second procedure—translabyrinthine combined with subtemporal way14
Intracapsular removal12 1
Mastoidectomy33 2
No surgery39 1
Previous surgical resection16 1
Subtotal petrosectomy/en bloc resection25 1
Subtotal resection41 2
Open in a new tab

Average overall follow-up was 52 months with the average time to recurrence being 12.9 months. (Note: This was based on 5 of the 61 cases [8.2%] with follow-up data.) Table 4 details the cases of recurrence of chondroblastoma. All had undergone subtotal resection of their tumors and three of five had had postoperative radiotherapy.

Table 4. Details of those Cases of Chondroblastoma in the Literature That Had Recurred.

Initial Surgery Radiotherapy Time to Recurrence Follow-Up Treatment
Craniotomy with attempted en bloc resection19 No 24 Further surgery—3 y follow-up post second surgery—no recurrence
Intracapsular removal12 Yes 6 Mx with curettage and RTx Follow-up 1 y postrecurrence—no abnormality detected
Excision46 No 6 Persistence
Curettage46 Yes 27 No
Initially subtemporal and subdural approach with intracapsular removal Yes 1.5 Yes—at 1.5 mo; second procedure attended + RTx – disease-free 36 mo later
Second procedure—translabyrinthine combined with subtemporal way14
Open in a new tab

Radiographic features of chondroblastoma in long bones are characterized by well-defined osteolytic lesions involving the epiphysis or secondary calcification centers.4 The diagnosis of chondroblastoma of the temporal bone is aided by imaging using the complementary modalities of CT and MRI. Plain skull X-ray is not helpful in the work-up. (Note: However, the typical findings are of a destructive lytic lesion of the temporal bone.3) CT imaging typically shows an expansile intraosseous soft tissue mass with internal calcification4 and occasional enhancement with intravenous contrast.5 Often there is a lytic nature to its growth.6 Further, CT imaging aids in the surgical planning for definitive resection of the tumor as well as defines the underlying bony anatomy. Lastly, it alerts the surgeon to possible intracranial involvement necessitating neurosurgical opinion/involvement in any potential surgical removal.

MRI typically shows a hypo- to intermediate signal on T-1 imaging and high signal on T-2 depending on the chronicity of potential hemorrhages into the mass.4 The appearance is that of a heterogeneous mass on T-2 likely due to highly vascular fibrous tissue and intense cellularity.5 Postgadolinium enhancement on T-2 imaging there is heterogeneity with components of marked hyperintensity.7 Lastly, MRI better delineates than CT the extent of intracranial/other soft tissue involvement, importantly that of dura and brain.

The three key diagnostic histopathological findings are the presence of chondroblasts, osteoclastic-like giant cells, and chondromyxoid stroma surrounding neoplastic cells.8 Fine needle aspiration (FNA) smears are moderately to markedly cellular and composed of osteoclast-type giant cells and mononucleated round to polygonal cells occurring individually or in loose aggregates.9

Microscopically chondroblastomas are cellular tumors with sheets of mononuclear polyhedral cells admixed with giant cells.7 A distinctive microscopic finding is the presence of zones of lacy calcification; “chicken wire” calcification. These tumors express s-100 and vimentin and this s-100 expression differentiates it from a giant cell tumor.7 Fig. 4A–F with associated captions further illustrates the histopathological findings. (Fig. 4A–C is from Case 1 and Fig. 4D–F is from Case 2.)

Figure 4.

Figure 4

Open in a new tab

(A) Case 1: A low power H&E view demonstrating interface of tumor (bottom right) with soft tissue (left) and bone destruction (top right). (B) Case 1: A medium power H&E view in which there is a cellular tumor composed of plump to spindled cells with admixed osteoclast-like multinucleated giant cells (bottom left). Entrapped trabecular bone is present (top). (C) Case 1: Focally, areas of “chicken-wire” pericellular calcification is a characteristic feature of chondroblastoma. (D) Case 2: In this low power H&E view there is soft tissue (top right) and bony (mid bottom) infiltration by tumor (left). Hemosiderin pigment is prominent. (E) Case 2: As well as cellular areas with many osteoclast-like giant cells (top right) as seen in the first case, there were also prominent light staining chondroid lobules. (F) Case 2: Higher magnification of the same area in 4E reveals the “pavimented” array of plump chondroblasts with surrounding pericellular calcification.

Suggested Approach

Due to the rarity of this tumor there was initially some doubt surrounding the definitive diagnosis. Preoperative imaging with both CT and MRI of the brain and petrous temporal bones with an open biopsy allowed a definitive or a reasonable differential diagnosis before surgery. Multidisciplinary expertise (particularly, confident histopathology input) via multidisciplinary clinics was and is vital in coming to definitive/reasonable diagnoses.

Of the 81 cases reported in the literature, 46 patients underwent a CT of the temporal bone and 35 underwent an MRI; all those undergoing MRI also underwent CT. (Note: 27 of the 81 cases had no mention of either preoperative imaging modality.) All cases after 1999, (31 in total) underwent a CT scan as part of their work-up. The same does not hold true for MRI, with reports up to 2007 not imaging their patients with this modality. It is our opinion that the contemporary work-up should include both CT and MRI of the primary site for reasons previously stated.

In the current review, 7 cases underwent FNA and 19 cases underwent open biopsy before definitive surgery and this allowed either a definitive or a reasonably certain diagnosis to be made before surgery. In our current series, the diagnosis of this relative low grade tumor preoperatively (using an open biopsy technique which we recommend) allowed the planning and execution of a more conservative surgical approach than would have been required for a malignant tumor, and thus less morbidity for the patient.

A work-up for metastatic disease, we believe, should be undertaken preoperatively. There is often no mention let alone a standard approach advocated regarding this part of the patient work-up in the current literature. Given that pelvic chondroblastoma tumors are known to metastatic to both lung and abdomen,10 (sometimes nondefinitive nature of the preoperative diagnosis) imaging should include, in our opinion, CT chest, abdomen, and pelvis. (Note: There are no cases of metastatic disease reported to date.)

Complete but conservative multispecialty surgical excision is the preferred therapeutic option and given that there have been no reported cases of metastatic disease, no adjuvant therapy is warranted.

In this review, heterogeneity of surgical approaches and resections was identified. As mentioned previously, given the low grade nature of this tumor we would advocate a complete but conservative multispecialty surgical resection. In our two cases, we employed either a partial temporal bone resection or an infratemporal fossa resection of tumor with both undergoing partial parotidectomy and facial nerve identification and preservation as part of the approach/resection. Other approaches have been advocated and if they too achieve complete resection of the tumor with a minimum of morbidity then they too can be pursued.

The option of radiotherapy has been described in the literature; however, this was reserved for recurrent tumors.11 In this current review, the role of radiotherapy is not able to be clearly defined. There is no role for chemotherapy.

Recurrence of these tumors is a possibility, particularly with subtotal resection therefore, long-term follow-up is required. In our series (18 and 78 months postoperative, respectively) no recurrence has occurred.

Lastly, baseline formal audiovestibular function testing should be performed preoperatively in all cases, based on presenting complaint.

Conclusion

Chondroblastoma of the temporal bone is an exceedingly rare tumor with diagnosis based on detailed multimodality imaging techniques, biopsy, and multidisciplinary clinic case review. The tumor is best managed with complete surgical excision. The use of radiotherapy is likely best reserved for recurrent/persistent tumor and long-term follow-up for recurrence is required.

References

  • 1.Kutz J W Jr, Verma S, Tan H T, Lo W W, Slattery W H III, Friedman R A. Surgical management of skull base chondroblastoma. Laryngoscope. 2007;117(5):848–853. doi: 10.1097/MLG.0b013e3180337da6. [DOI] [PubMed] [Google Scholar]
  • 2.Cotran R, Kumar V, Robbins S. Pennsylvania: WB Saunders Company; 1994. Robbins: Pathological Basis of Disease. 5th ed. [Google Scholar]
  • 3.Spahr J, Elzay R P, Kay S, Frable W J. Chondroblastoma of the temporomandibular joint arising from articular cartilage: a previously unreported presentation of an uncommon neoplasm. Spahr JElzay RPFrable WJ. Oral Surg Oral Med Oral Pathol. 1982;54(4):430–435. doi: 10.1016/0030-4220(82)90390-5. [DOI] [PubMed] [Google Scholar]
  • 4.Flowers C H, Rodriguez J, Naseem M, Reyes M M, Verano A S. MR of benign chondroblastoma of the temporal bone. AJNR Am J Neuroradiol. 1995;16(2):414–416. [PMC free article] [PubMed] [Google Scholar]
  • 5.Dran G, Niesar E, Vandenbos F, Noel G, Paquis P, Lonjon M. Chondroblastoma of the apex portion of petrousal bone. Childs Nerv Syst. 2007;23(2):231–235. doi: 10.1007/s00381-006-0201-9. [DOI] [PubMed] [Google Scholar]
  • 6.Selesnick S H, Levine J M. Chondroblastoma of the temporal bone: consistent middle fossa involvement. Skull Base Surg. 1999;9(4):301–305. doi: 10.1055/s-2008-1058141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kurokawa R Uchida K Kawase T Surgical treatment of temporal bone chondroblastoma Surg Neurol 2005633265–268., discussion 268 [DOI] [PubMed] [Google Scholar]
  • 8.Granados R, Martín-Hita A, Rodríguez-Barbero J M, Murillo N. Fine-needle aspiration cytology of chondroblastoma of soft parts: case report and differential diagnosis with other soft tissue tumors. Diagn Cytopathol. 2003;28(2):76–81. doi: 10.1002/dc.10233. [DOI] [PubMed] [Google Scholar]
  • 9.Cabrera R A, Almeida M, Mendonça M E, Frable W J. Diagnostic pitfalls in fine-needle aspiration cytology of temporomandibular chondroblastoma: report of two cases. Diagn Cytopathol. 2006;34(6):424–429. doi: 10.1002/dc.20458. [DOI] [PubMed] [Google Scholar]
  • 10.Lin P P, Thenappan A, Deavers M T, Lewis V O, Yasko A W. Treatment and prognosis of chondroblastoma. Clin Orthop Relat Res. 2005;438:103–109. doi: 10.1097/01.blo.0000179591.72844.c3. [DOI] [PubMed] [Google Scholar]
  • 11.Harner S G, Cody D T, Dahlin D C. Benign chondroblastoma of the temporal bone. Otolaryngol Head Neck Surg. 1979;87(2):229–236. doi: 10.1177/019459987908700213. [DOI] [PubMed] [Google Scholar]
  • 12.Anim J T, Baraka M E. Chondroblastoma of temporal bone: unusual histologic features. Ann Otol Rhinol Laryngol. 1986;95(3 Pt 1):260–263. doi: 10.1177/000348948609500309. [DOI] [PubMed] [Google Scholar]
  • 13.Ben Salem D, Allaoui M, Dumousset E. et al. Chondroblastoma of the temporal bone associated with a persistent hypoglossal artery. Acta Neurochir (Wien) 2002;144(12):1315–1318. doi: 10.1007/s00701-002-1025-3. [DOI] [PubMed] [Google Scholar]
  • 14.Bertoni F, Unni K K, Beabout J W, Harner S G, Dahlin D C. Chondroblastoma of the skull and facial bones. Am J Clin Pathol. 1987;88(1):1–9. doi: 10.1093/ajcp/88.1.1. [DOI] [PubMed] [Google Scholar]
  • 15.Bian L G, Sun Q F, Zhao W G, Shen J K, Tirakotai W, Bertalanffy H. Temporal bone chondroblastoma: a review. Neuropathology. 2005;25(2):159–164. doi: 10.1111/j.1440-1789.2005.00597.x. [DOI] [PubMed] [Google Scholar]
  • 16.Blaauw G, Prick J J, Versteege C. Chondroblastoma of the temporal bone. Neurosurgery. 1988;22(6 Pt 1):1102–1107. doi: 10.1227/00006123-198806010-00026. [DOI] [PubMed] [Google Scholar]
  • 17.Cares H L, Terplan K. Chondroblastoma of the skull. Case report. J Neurosurg. 1971;35(5):614–618. doi: 10.3171/jns.1971.35.5.0614. [DOI] [PubMed] [Google Scholar]
  • 18.Dahlin D C, Ivins J C. Benign chondroblastoma. A study of 125 cases. Cancer. 1972;30(2):401–413. doi: 10.1002/1097-0142(197208)30:2<401::aid-cncr2820300216>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  • 19.Denko J V, Krauel L H. Benign chondroblastoma of bone; an unusual localization in temporal bone. AMA Arch Pathol. 1955;59(6):710–711. [PubMed] [Google Scholar]
  • 20.Fares G, Aïdan P, Bouccara D, Molas G, Gomulinski L, Sterkers O. [Chondroblastoma of the temporal bone. Apropos of a case] Ann Otolaryngol Chir Cervicofac. 1997;114(4):130–133. [PubMed] [Google Scholar]
  • 21.Feely M, Keohane C. Chondroblastoma of the temporal bone case report and literature review. Ann Otol Rhinol Laryngol. 1992;101:764–769. doi: 10.1177/000348949210100909. [DOI] [PubMed] [Google Scholar]
  • 22.Gaudet E L Jr, Nuss D W, Johnson D H Jr, Miranne L S Jr. Chondroblastoma of the temporal bone involving the temporomandibular joint, mandibular condyle, and middle cranial fossa: case report and review of the literature. Cranio. 2004;22(2):160–168. doi: 10.1179/crn.2004.021. [DOI] [PubMed] [Google Scholar]
  • 23.Hirth R, Städtler F, Piepgras U. [An intracranial chondroblastoma] Arch Psychiatr Nervenkr. 1972;216(4):359–369. doi: 10.1007/BF00355305. [DOI] [PubMed] [Google Scholar]
  • 24.Hong S M, Park Y K, Ro J Y. Chondroblastoma of the temporal bone: a clinicopathologic study of five cases. J Korean Med Sci. 1999;14(5):559–564. doi: 10.3346/jkms.1999.14.5.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Horn K L, Hankinson H, Nagel B, Erasmus M. Surgical management of chondroblastoma of the temporal bone. Otolaryngol Head Neck Surg. 1990;102(3):264–269. doi: 10.1177/019459989010200310. [DOI] [PubMed] [Google Scholar]
  • 26.Ishikawa E, Tsuboi K, Onizawa K. et al. Chondroblastoma of the temporal base with high mitotic activity. Neurol Med Chir (Tokyo) 2002;42(11):516–520. doi: 10.2176/nmc.42.516. [DOI] [PubMed] [Google Scholar]
  • 27.Kobayashi Y, Murakami R, Toba M. et al. Chondroblastoma of the temporal bone. Skeletal Radiol. 2001;30(12):714–718. doi: 10.1007/s002560100435. [DOI] [PubMed] [Google Scholar]
  • 28.Koerbel A, Loewenheim H, Beschorner R. et al. Surgical treatment and outcomes of temporal bone chondroblastoma. Eur Arch Otorhinolaryngol. 2008;265:1447–1454. doi: 10.1007/s00405-008-0660-6. [DOI] [PubMed] [Google Scholar]
  • 29.Leong H K, Chong P Y, Sinniah R. Temporal bone chondroblastoma: big and small. J Laryngol Otol. 1994;108(12):1115–1119. doi: 10.1017/s0022215100129068. [DOI] [PubMed] [Google Scholar]
  • 30.Mizumatsu S, Sakai K, Nishimura T. et al. [Gamma knife radiosurgery for temporal bone chondroblastoma: case report] No Shinkei Geka. 2008;36(1):65–69. [PubMed] [Google Scholar]
  • 31.Moon I S, Kim J, Lee H K, Lee W S. Surgical treatment and outcomes of temporal bone chondroblastoma. Eur Arch Otorhinolaryngol. 2008;265(12):1447–1454. doi: 10.1007/s00405-008-0660-6. [DOI] [PubMed] [Google Scholar]
  • 32.Moorthy R K, Daniel R T, Rajshekhar V, Chacko G. Skull base chondroblastoma: a case report. Neurol India. 2002;50(4):534–536. [PubMed] [Google Scholar]
  • 33.Muntané A, Valls C, Angeles de Miquel M A, Pons L C. Chondroblastoma of the temporal bone: CT and MR appearance. AJNR Am J Neuroradiol. 1993;14(1):70–71. [PMC free article] [PubMed] [Google Scholar]
  • 34.Narita Y, Morimoto T, Nishikawa R. et al. [Chondroblastoma of the temporal bone—report of a case and a review of the literature of 54 cases] No To Shinkei. 1992;44(2):143–148. [PubMed] [Google Scholar]
  • 35.Rodríguez Paramás A, Lendoiro Otero C, González García J A, Souviron Encabo R, Scola Yurrita B. [Temporal bone chondroblastoma. A clinical case and literature review] Acta Otorrinolaringol Esp. 2006;57(7):336–338. doi: 10.1016/s0001-6519(06)78723-4. [DOI] [PubMed] [Google Scholar]
  • 36.Piepgras U, Hirth R, Städtler F, Kammerer V. Chondroblastoma of the temporal bone, an unusual cause of increasing intracranial pressure. Neuroradiology. 1972;4(1):25–29. doi: 10.1007/BF00344805. [DOI] [PubMed] [Google Scholar]
  • 37.Politi M, Consolo U, Panziera G, Capelli P, Bonetti F. Chondroblastoma of the temporal bone. Case report. J Craniomaxillofac Surg. 1991;19(7):319–322. doi: 10.1016/s1010-5182(05)80340-3. [DOI] [PubMed] [Google Scholar]
  • 38.Pontius A, Reder P, Ducic Y. Diagnostic pitfalls in fine needle aspiration cytology of temporomandibular chondroblastoma: report of two cases. Diagn Cytopathol. 2006;34(6):424–429. doi: 10.1002/dc.20458. [DOI] [PubMed] [Google Scholar]
  • 39.Shimizu J, Kaito N, Akiba Y. et al. [Chondroblastoma of the temporal bone: a case report] No Shinkei Geka. 1997;25(6):555–559. [PubMed] [Google Scholar]
  • 40.Spjut H J, Dorfmen H D, Fechner R E, Ackerman L V. Gamma Knife radiosurgery for temporal bone chondroblastoma: case report. No Shinkei Geka. 2008;36(1):65–69. [PubMed] [Google Scholar]
  • 41.Tanohata K, Noda M, Katoh H. et al. Chondroblastoma of temporal bone. Neuroradiology. 1986;28(4):367–370. doi: 10.1007/BF00333449. [DOI] [PubMed] [Google Scholar]
  • 42.Vandenberg H J, Coley B L. Chondroblastoma of the temporal bone: a case report. No Shinkei Geka. 1950;25(6):555–559. [PubMed] [Google Scholar]
  • 43.Varvares M A, Cheney M L, Goodman M L, Ceisler E, Montgomery W W. Chondroblastoma of the temporal bone. Case report and literature review. Ann Otol Rhinol Laryngol. 1992;101(9):763–769. doi: 10.1177/000348949210100909. [DOI] [PubMed] [Google Scholar]
  • 44.Velizarov A, Lolova I, Hristov V. Rare localization of chondroblastoma. Nauchni Tr Vissh Med Inst Sofiia. 1971;50(2):39–46. [PubMed] [Google Scholar]
  • 45.Watanabe N, Yoshida K, Shigemi H, Kurono Y, Mogi G. Temporal bone chondroblastoma. Otolaryngol Head Neck Surg. 1999;121(3):327–330. doi: 10.1016/S0194-5998(99)70201-9. [DOI] [PubMed] [Google Scholar]
  • 46.Hong S M, Park Y K, Ro J Y. Primary tumors of the cranial bones, surgery. Gynecol Obstet (Paris) 1950;90:602–612. [PubMed] [Google Scholar]

Articles from Skull Base Reports are provided here courtesy of Thieme Medical Publishers

RESOURCES